16 Dec. 2021
This document is a prioritization toolkit providing a set of action steps to follow in the event of an impending surge in cases of COVID-19 in health-care facilities. The document provides a framework for action steps to be followed within 2-4 weeks of identification of a surge or resu...rgence of cases, and is accompanied by references to existing WHO resources to assist with managing each step. This document is intended for emergency operations centre focal persons for health facilities, incident managers, health-care managers and administrators, and infection prevention and control focal persons.
more
of highly contagious viruses (of the Ebola or Marburg type) in the context of an epidemic outbreak in West Africa
AIDSTAR-One | CASE STUDY SERIES November 2012
Evaluation and Diagnosis of Penicillin Allergy for Healthcare Professionals
Developmental disorders
Chapter C.2
2014 Edition
Rev. Latino-Am. Enfermagem 2019;27:e3086 DOI: 10.1590/1518-8345.2608.3086
For Families and Caregivers in Sierra Leone
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 11, November 2017
This manual is about the basic nursing care - desinfection, cleaning, sterilization, nursing documentation, hygiene, surgical care and preparation and much more. This booklet has been prepared by the NED Volunteers Foundation.
CARDIOVASCULAR AFRICA JOURNAL OF AFRICA
Volume 27, No 4, July/August 2016
Handout presentations in PDF for illustrating lectures
Accessed May 2014
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced COPD-related exacerbations, associated hospitalisati...ons and duration of hospital stay. Both the South African Thoracic Society (SATS) and Global Initiative for Chronic Obstructive Lung Disease (GOLD), guidelines recommend the use of long acting anticholinergic drugs (or long acting beta agonists) in moderate to very severe disease as defined by lung function (FEV1). The most up to date guideline, utilizing the GRADE methodology (European Respiratory Society guidelines of 2017), confirms their superiority over long acting β agonists (LABA) as monotherapy for COPD in that LAMA's have demonstrated greater efficacy in terms of exacerbation reduction, with similar safety profile.2 These recommnedations are supported by published peer-reviewed
evidence including individual papers and Cochrane reviews.
more
Guide to access the National AMR Surveillance Dashboard